Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC48202Treprostinil (diethanolamine salt)CAS: 830354-48-8纯度: >98.00%
An agonist of IP 2 , DP 2 , and EP 2 receptors
- GC48206Trimethylamine-d9 N-oxideCAS: 1161070-49-0纯度: >99.00%
An internal standard for the quantification of trimethylamine N-oxide
- GC48243Vardenafil-d5CAS: 1189685-70-8纯度: >99.00%
An internal standard for the quantification of vardenafil
- GC48283α-Linolenic Acid-d14CAS: 1622944-40-4纯度: >99.00%
An internal standard for the quantification of α-Linolenic acid
- GC48469Moexipril-d5CAS: 1356929-49-1纯度: >99.00%
An internal standard for the quantification of moexipril
- GC48498Sarpogrelate-d3 (hydrochloride)CAS: 2934185-00-7纯度: >99.00%
An internal standard for the quantification of sarpogrelate
- GC48508(4-Carboxybutyl-d4)triphenylphosphonium (bromide)CAS: 42932-63-8纯度: >99.00%
An internal standard for the quantification of (4-carboxybutyl)triphenylphosphonium
- GC48513Quinapril-d5CAS: 1279029-79-6纯度: >99.00%
An internal standard for the quantification of quinapril
- GC48583Rizatriptan-d6 (benzoate salt)CAS: 1216984-85-8纯度: >99.00%
An internal standard for the quantification of rizatriptan
- GC48584Naftopidil-d5CAS: 2747918-58-5纯度: >99.00%
An internal standard for the quantification of naftopidil
- GC48612Propafenone-d5 (hydrochloride)CAS: 1346605-05-7纯度: >99.00%
An internal standard for the quantification of propafenone
- GC48661Methylatropine (nitrate)CAS: 52-88-0纯度: >95.00%
A muscarinic acetylcholine receptor antagonist
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC48202 | Treprostinil (diethanolamine salt) | 830354-48-8 | >98.00% | |
An agonist of IP 2 , DP 2 , and EP 2 receptors | ||||
| GC48206 | Trimethylamine-d9 N-oxide | 1161070-49-0 | >99.00% | |
An internal standard for the quantification of trimethylamine N-oxide | ||||
| GC48229 | Urotensin II (goby) (trifluoroacetate salt) | - | >95.00% | |
A peptide vasoconstrictor | ||||
| GC48243 | Vardenafil-d5 | 1189685-70-8 | >99.00% | |
An internal standard for the quantification of vardenafil | ||||
| GC48262 | YM-90K (hydrochloride hydrate) | - | >98.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48283 | α-Linolenic Acid-d14 | 1622944-40-4 | >99.00% | |
An internal standard for the quantification of α-Linolenic acid | ||||
| GC48343 | Gap19 (trifluoroacetate salt) | - | >95.00% | |
An inhibitor of Cx43 hemichannels | ||||
| GC48356 | Psychotridine | 52617-25-1 | >95.00% | |
An alkaloid with diverse biological activities | ||||
| GC48406 | PSI (trifluoroacetate salt) | - | >95.00% | |
A proteasome inhibitor | ||||
| GC48418 | N-(2-Poc-ethyl)betulin amide | - | >95.00% | |
An alkyne derivative of betulin | ||||
| GC48432 | KB-130015 | 147030-48-6 | >95.00% | |
An antiarrhythmic agent | ||||
| GC48449 | 28-(Poc-amino)betulin | - | >95.00% | |
An alkyne derivative of betulin | ||||
| GC48469 | Moexipril-d5 | 1356929-49-1 | >99.00% | |
An internal standard for the quantification of moexipril | ||||
| GC48498 | Sarpogrelate-d3 (hydrochloride) | 2934185-00-7 | >99.00% | |
An internal standard for the quantification of sarpogrelate | ||||
| GC48508 | (4-Carboxybutyl-d4)triphenylphosphonium (bromide) | 42932-63-8 | >99.00% | |
An internal standard for the quantification of (4-carboxybutyl)triphenylphosphonium | ||||
| GC48513 | Quinapril-d5 | 1279029-79-6 | >99.00% | |
An internal standard for the quantification of quinapril | ||||
| GC48538 | MRS2179 (ammonium salt hydrate) | - | >98.00% | |
A P2Y 1 receptor antagonist | ||||
| GC48583 | Rizatriptan-d6 (benzoate salt) | 1216984-85-8 | >99.00% | |
An internal standard for the quantification of rizatriptan | ||||
| GC48584 | Naftopidil-d5 | 2747918-58-5 | >99.00% | |
An internal standard for the quantification of naftopidil | ||||
| GC48589 | Bassianin | 54278-73-8 | >95.00% | |
A fungal metabolite | ||||
| GC48612 | Propafenone-d5 (hydrochloride) | 1346605-05-7 | >99.00% | |
An internal standard for the quantification of propafenone | ||||
| GC48620 | BPKDi | 1201673-28-0 | >98.00% | |
A PKD inhibitor | ||||
| GC48621 | INNO-8875 | 871108-05-3 | >98.00% | |
An adenosine A 1 receptor agonist | ||||
| GC48661 | Methylatropine (nitrate) | 52-88-0 | >95.00% | |
A muscarinic acetylcholine receptor antagonist | ||||